In today's rapidly evolving threat landscape, cybersecurity is more crucial than ever. Advanced persistent threats (APTs) and ...

Key Insights The projected fair value for Vector is NZ$6.86 based on Dividend Discount Model Current share price ...

Warcraft earned around $440 million worldwide, making it the No. 4 highest-grossing video game movie ever. It only made $47 ...

Oracle’s cloud may be been in the running to be the host of a massive AI training system for Elon Musk’s xAI startup, with a ...

The Hawai‘i Department of Health has confirmed a new travel-related case of dengue virus on Maui, bringing the total number ...

Cybercriminals are using AI for help in planning and conducting cyberattacks—but cybersecurity vendors are fighting back.

State officials are warning the public after confirming a new travel-related case of the dengue virus on Maui. According to ...

Oscar-nominated John Malkovich makes a brief appearance in the teaser trailer for "The Fantastic Four: First Steps" that Marvel debuted earlier this month. Except for a distinct white beard and hairdo ...

AppLovin's expansion beyond gaming appears to have gained momentum in Q4. See why it is difficult for APP stock to continue ...

Oracle's AI Cloud demand is surging, presenting huge potential for long-term growth, despite a recent 16% drop in share price ...

The Hawai‘i Department of Health has confirmed a new travel-related case of dengue virus on Oʻahu, bringing the total number ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.